IP Library Granted Patent US 9,107,888
Granted Patent B2
US 9,107,888 · App. 13/978,258 · Granted Aug 18, 2015

Aqueous liquid bromfenac composition having preservative efficacy

Inventors: Shuichi Nishihata (Hyogo, JP); Wakiko Asayama (Hyogo, JP); Suzuka Iemoto (Hyogo, JP)
Assignee: SENJU PHARMACEUTICAL CO., LTD.
A61K31/196A61K9/08A61K31/14A61K47/18A61K47/186A61K9/0043A61K9/0046A61K9/0048
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,107,888
App. No.
13/978,258
Granted
Aug 18, 2015
Kind
B2
Abstract

An aqueous liquid bromfenac composition containing (a) bromfenac or a salt thereof and (b) benzalkonium chloride, characterized by that the composition has preservative efficacy and that the concentration of (b) benzalkonium chloride is higher than 0.0005% and lower than 0.005%.

Claims (9)

1. An aqueous liquid bromfenac composition comprising (a) bromfenac or a salt thereof, (b) benzalkonium chloride, and (c) at least one compound selected from the group consisting of a non-ionic surfactant and a water-soluble polymer, wherein the composition has preservative efficacy and the concentration of (a) bromfenac or a salt thereof is 0.05% to 0.15% and (b) benzalkonium chloride is 0.001% to 0.002%, wherein when the composition comprises the non-ionic surfactant, the concentration of the non-ionic surfactant is 0.025% or higher and lower than 0.25%, and/or wherein when the composition comprises the water-soluble polymer, the concentration of the water-soluble polymer is 0.01% to 1.4%.

2. The aqueous liquid composition of claim 1 , wherein the composition comprises the non-ionic surfactant.

3. The aqueous liquid composition of claim 1 , wherein the non-ionic surfactant is polysorbate 80.

4. The aqueous liquid composition of claim 1 , wherein the concentration of the non-ionic surfactant is 0.1% to 0.15%.

5. The aqueous liquid composition of claim 1 , wherein the composition comprises the water-soluble polymer.

6. The aqueous liquid composition of claim 1 , wherein the water-soluble polymer is at least one compound selected from the group consisting of hydroxyethyl cellulose and povidone.

7. The aqueous liquid composition of claim 1 , which is an ophthalmic solution, a nasal solution, or an otic solution.

8. An aqueous liquid bromfenac composition comprising (a) bromfenac or a salt thereof, (b) benzalkonium chloride, and (c) a non-ionic surfactant, wherein the composition has preservative efficacy and the concentration of (a) bromfenac or a salt thereof is 0.05% to 0.15% and (b) benzalkonium chloride is 0.001% to 0.002%, and wherein the non-ionic surfactant is polysorbate 80, and the concentration of the polysorbate 80 is 0.1% to 0.15%.

9. An aqueous liquid bromfenac composition comprising (a) bromfenac or a salt thereof, (b) benzalkonium chloride, and (c) a non-ionic surfactant, wherein the composition has preservative efficacy and the concentration of (a) bromfenac or a salt thereof is 0.05% to 0.15% and (b) benzalkonium chloride is 0.001%, and wherein the non-ionic surfactant is polysorbate 80, and the concentration of the polysorbate 80 is 0.1% to 0.15%.

Assignments (2)
CHANGE OF ADDRESS Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2013
From: NISHIHATA, SHUICHI; ASAYAMA, WAKIKO; IEMOTO, SUZUKA
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 030958/0702 →
Priority Claims (3)
JP 2011-007898 · Jan 18, 2011 · national
JP 2011-199480 · Sep 13, 2011 · national
JP 2011-289640 · Dec 28, 2011 · national
Continuity (1)
Related Publication 20130281537A1 · Oct 24, 2013